Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 426Breast 98Genitourinary 80Thoracic 60Gastrointestinal 58Dermatologic 51CNS 50Sarcoma 48Lymphoid 46Other hematologic neoplasm 45Plasma cell 38Myeloid 34Head & Neck 26Other solid neoplasm 10Endocrine 8Other 3Classical hematology 3NET 2

Conditions

Obesity 219Neoplasms 82Mucositis 66Sexual Dysfunction, Physiological 65Breast Neoplasms 64Polycystic Ovary Syndrome 56Overweight 55Dyspnea 32Motor Activity 30Constipation 30Head and Neck Neoplasms 28Prostatic Neoplasms 25Weight Loss 24Multiple Endocrine Neoplasia Type 1 19Colorectal Neoplasms 18Pain 16Diabetes Mellitus 16Stomatitis 15Lung Neoplasms 15Opioid-Induced Constipation 14Depression 14Cardiovascular Diseases 14Insulin Resistance 13Endometrial Neoplasms 13Sexuality 11Sexual Dysfunctions, Psychological 11Diabetes Mellitus, Type 2 11Fatigue 10Anxiety Disorders 10Stomach Neoplasms 8

Interventions

Octreotide 1Dehydroepiandrosterone 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Carcinoma, Ovarian Epithelial × Other × Clear all
NCT02096783 2019-11-18

Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer

University of Wisconsin, Madison

Phase NA Completed
15 enrolled
GynecologicOther

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Uterine Cervical Neoplasms, Sexual Dysfunction, Physiological, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gestational Trophoblastic Disease

NCT01376349 2019-02-07

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Alliance for Clinical Trials in Oncology

Phase 3 Completed
464 enrolled 8 charts
BreastGynecologicOther

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Sexual Dysfunction, Physiological, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT00004895 2012-06-06

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Northwestern University

Phase 2 Completed
GastrointestinalGynecologicOtherSarcoma

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Colonic Neoplasms, Constipation, Intestinal Obstruction, Nausea, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Vomiting, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡